Genprex, Inc.
GNPX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.00 | -0.03 | -0.23 | 0.23 |
| FCF Yield | -502.68% | -197.27% | -25.67% | -23.30% |
| EV / EBITDA | -0.09 | -0.19 | -2.04 | -1.12 |
| Quality | ||||
| ROIC | -1,306.92% | -419.01% | -106.99% | -50.08% |
| Gross Margin | 0.00% | 0.00% | 0.00% | 0.00% |
| Cash Conversion Ratio | 0.81 | 0.80 | 0.75 | 0.73 |
| Growth | ||||
| Revenue 3-Year CAGR | – | – | – | – |
| Free Cash Flow Growth | 30.88% | -39.08% | -24.15% | 11.70% |
| Safety | ||||
| Net Debt / EBITDA | 0.08 | 0.22 | 0.88 | 1.87 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | -58,586.24 | -33,999.44 | -6.78 | -15,763.57 |